Gaurav Gupta
Direttore/Membro del Consiglio presso NewAmsterdam Pharma BV
Posizioni attive di Gaurav Gupta
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Gaurav Gupta
Precedenti posizioni note di Gaurav Gupta
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Direttore/Membro del Consiglio | - | - |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Analista di Private Equity | - | - |
Formazione di Gaurav Gupta
| Stanford University School of Medicine | Doctorate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Paesi Bassi | 3 |
Posizioni
| Doctorate Degree | 2 |
| Director/Board Member | 2 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Finance |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Gaurav Gupta
- Esperienza
